Alirocumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Alirocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $341 million on Alirocumab across 443,000 claims for 92,000 beneficiaries.
Alirocumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $257.73 to $258.01 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$257.73 – $258.01
per ML
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Regeneron Pharmaceuticals, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
PCSK9 Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ALIROCUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PRALUENT 150 MG/ML PEN | $258.0073 per ML | -0.01% |
PRALUENT 75 MG/ML PEN | $257.7316 per ML | 0.00% |
Frequently Asked Questions
What is Alirocumab used to treat?
Alirocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Alirocumab?
In 2024, Medicare Part D spent $341 million on Alirocumab across 443,000 claims for 92,000 beneficiaries.
How many Alirocumab products are on the market?
The Alirocumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Alirocumab?
NADAC reference prices for Alirocumab range from $257.7316 to $258.0073 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Alirocumab?
1 manufacturer lists Alirocumab in NADAC. Ranked by number of NDCs, the largest are Regeneron Pharmaceuticals, Inc. (2).
How has the price of Alirocumab changed recently?
Over the past 7 days, 0 Alirocumab NDCs rose and 1 fell, with a market-wide average change of -0.0%.